Rituximab improves response rates, event-free survival in MALT lymphoma

NEW YORK (Reuters Health) - Adding rituximab to chlorambucil improves response rates and event-free survival, but not overall survival, in patients with MALT lymphoma, new data show.
Source: Modern Medicine - Category: Journals (General) Source Type: news